Anyone surprised INCY only closed up a few percentage points after approval of their lead drug?
I'm not surprised but definitively disappointed. INCY has taken a beating in the last few months. Seems like Biotech is in one of it's out of favor trends these days.
FWIW, the mean/median sell-side price tag is around $23.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.